tranexamic acid has been researched along with Glomerulonephritis in 6 studies
Tranexamic Acid: Antifibrinolytic hemostatic used in severe hemorrhage.
Glomerulonephritis: Inflammation of the renal glomeruli (KIDNEY GLOMERULUS) that can be classified by the type of glomerular injuries including antibody deposition, complement activation, cellular proliferation, and glomerulosclerosis. These structural and functional abnormalities usually lead to HEMATURIA; PROTEINURIA; HYPERTENSION; and RENAL INSUFFICIENCY.
Excerpt | Relevance | Reference |
---|---|---|
"Recent data indicated that aging accelerated glomerular fibrin deposition induced by lipopolysaccharide (LPS) in mice." | 3.73 | Effects of alterations of glomerular fibrin deposition on renal inflammation in rats at different age stages. ( Chen, X; Feng, Z; Hong, Q; Lin, S; Lu, Y; Shi, S; Sun, X; Wang, J; Xi, C, 2005) |
"Tranexamic acid is a potent antifibrinolytic drug frequently used in the treatment of haematuria and a number of other haemorrhagic conditions." | 1.26 | Special considerations with regard to the dosage of tranexamic acid in patients with chronic renal diseases. ( Andersson, L; Eriksson, O; Hedlund, PO; Kjellman, H; Lindqvist, B, 1978) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (16.67) | 18.7374 |
1990's | 1 (16.67) | 18.2507 |
2000's | 3 (50.00) | 29.6817 |
2010's | 1 (16.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Revollo, JY | 1 |
Cuffy, MC | 1 |
Witte, DP | 1 |
Paterno, F | 1 |
Alloway, RR | 1 |
Woodle, ES | 1 |
Kitamura, H | 1 |
Matsui, I | 1 |
Itoh, N | 1 |
Fujii, T | 1 |
Aizawa, M | 1 |
Yamamoto, R | 1 |
Okuno, A | 1 |
Okazaki, Y | 1 |
Fujita, Y | 1 |
Kuwayama, Y | 1 |
Imai, E | 1 |
Fujii, M | 1 |
Xi, C | 1 |
Chen, X | 1 |
Sun, X | 1 |
Shi, S | 1 |
Feng, Z | 1 |
Wang, J | 1 |
Hong, Q | 1 |
Lu, Y | 1 |
Lin, S | 1 |
Huang, Y | 1 |
Border, WA | 1 |
Lawrence, DA | 1 |
Noble, NA | 1 |
Andersson, L | 1 |
Eriksson, O | 1 |
Hedlund, PO | 1 |
Kjellman, H | 1 |
Lindqvist, B | 1 |
Foster, GR | 1 |
Carmichael, DJ | 1 |
Kermode, A | 1 |
Hulme, B | 1 |
Gabriel, JR | 1 |
Cattell, V | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Intravenous Tranexamic Acid and Intraoperative Visualization During Functional Endoscopic Sinus Surgery: A Double Blind Randomized Controlled Trial[NCT01111669] | 28 participants (Actual) | Interventional | 2009-08-31 | Completed | |||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
6 other studies available for tranexamic acid and Glomerulonephritis
Article | Year |
---|---|
Case Report: Hemolytic Anemia Following Deceased Donor Renal Transplantation Associated With Tranexamic Acid Administration for Disseminated Intravascular Coagulation.
Topics: Aged; Anemia, Hemolytic; Antifibrinolytic Agents; Diabetes Mellitus, Type 2; Disseminated Intravascu | 2015 |
Tranexamic acid-induced visual impairment in a hemodialysis patient.
Topics: Angiography; Antifibrinolytic Agents; Drug Overdose; Glomerulonephritis; Humans; Male; Middle Aged; | 2003 |
Effects of alterations of glomerular fibrin deposition on renal inflammation in rats at different age stages.
Topics: Aging; Animals; Antifibrinolytic Agents; Antigens, CD; Blotting, Northern; Cadherins; Chemokine CCL2 | 2005 |
Noninhibitory PAI-1 enhances plasmin-mediated matrix degradation both in vitro and in experimental nephritis.
Topics: Animals; Antifibrinolytic Agents; Cells, Cultured; Collagen Type I; Extracellular Matrix; Fibrinolys | 2006 |
Special considerations with regard to the dosage of tranexamic acid in patients with chronic renal diseases.
Topics: Biological Availability; Chronic Disease; Creatinine; Cyclohexanecarboxylic Acids; Glomerulonephriti | 1978 |
Extensive crescent formation with antifibrinolytic therapy in a case of diffuse endocapillary glomerulonephritis.
Topics: Acute Disease; Acute Kidney Injury; Cyclohexanecarboxylic Acids; Female; Glomerulonephritis; Humans; | 1990 |